Xueya Feng
Overview
Explore the profile of Xueya Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manser M, Jeyanathan V, Jeyanathan M, Feng X, Dolovich M, Xing Z, et al.
Pharm Res
. 2023 Mar;
40(5):1165-1176.
PMID: 36991226
Purpose: Intratracheal delivery and consistent dosing of dry powder vaccines is especially challenging in mice. To address this issue, device design of positive pressure dosators and actuation parameters were assessed...
2.
Jeyanathan V, Afkhami S, DAgostino M, Zganiacz A, Feng X, Miller M, et al.
Front Immunol
. 2023 Feb;
14:1151809.
PMID: 36825013
[This corrects the article DOI: 10.3389/fimmu.2022.860399.].
3.
Manser M, Morgan B, Feng X, Rhem R, Dolovich M, Xing Z, et al.
Pharm Res
. 2022 Jul;
39(9):2315-2328.
PMID: 35854077
Purpose: Thermally stable, spray dried vaccines targeting respiratory diseases are promising candidates for pulmonary delivery, requiring careful excipient formulation to effectively encapsulate and protect labile biologics. This study investigates the...
4.
Jeyanathan V, Afkhami S, DAgostino M, Zganiacz A, Feng X, Miller M, et al.
Front Immunol
. 2022 Jun;
13:860399.
PMID: 35757753
Infectious diseases of the respiratory tract are one of the top causes of global morbidity and mortality with lower respiratory tract infections being the fourth leading cause of death. The...
5.
Manser M, Feng X, Xing Z, Cranston E, Thompson M
Int J Pharm
. 2022 Feb;
617:121602.
PMID: 35189314
Increasing viral dosage within dry powder vaccines reduces the powder mass required to elicit an immune response through pulmonary delivery. This work analyzes how cryoprotective agents affect viral activity, particle...
6.
Peng H, Zheng J, Su Q, Feng X, Peng M, Gong L, et al.
Onco Targets Ther
. 2020 Oct;
13:10667-10675.
PMID: 33116643
Background: Many studies found that VPS53, one of the subunits of the golgi-associated retrograde protein (GARP) complexes, was aberrantly expressed in human diseases. Aim: This study investigated the functions and...
7.
Li Q, Chen R, Yu Y, Wang X, Feng X, Jiang L, et al.
Medicine (Baltimore)
. 2020 Oct;
99(40):e22598.
PMID: 33019480
Background: Early diagnosis and treatment of the osteonecrosis of the femoral head (ONFH), a refractory disease, is imperative to prevent femoral head collapse; however, the existing solutions remain controversial. This...
8.
Mu J, Jeyanathan M, Small C, Zhang X, Roediger E, Feng X, et al.
Mol Ther
. 2009 Mar;
17(6):1093-100.
PMID: 19319120
Recombinant virus-vectored vaccines hold great promise for tuberculosis (TB) vaccination strategies. However, there is a lack of side-by-side comparative investigations to dissect the functional differences and support the advantage of...